These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7787939)

  • 1. Therapy of pediatric AIDS.
    Wu LR; Capparelli EV; Connor JD
    Curr Opin Pediatr; 1995 Apr; 7(2):214-9. PubMed ID: 7787939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection in children.
    Hoernle EH; Reid TE
    Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS: Part II.
    Kessler HA; Bick JA; Pottage JC; Benson CA
    Dis Mon; 1992 Oct; 38(10):691-764. PubMed ID: 1396036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
    Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH
    J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric human immunodeficiency virus infection.
    Domachowske JB
    Clin Microbiol Rev; 1996 Oct; 9(4):448-68. PubMed ID: 8894346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meeting of the Pediatric Work Group AIDS in Germany (PAAD) on May 8-9, 1998 in Frankfurt/Main].
    Funk M
    Klin Padiatr; 1999; 211(2):96-7. PubMed ID: 10407820
    [No Abstract]   [Full Text] [Related]  

  • 8. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.
    Luzuriaga K; Bryson Y; Krogstad P; Robinson J; Stechenberg B; Lamson M; Cort S; Sullivan JL
    N Engl J Med; 1997 May; 336(19):1343-9. PubMed ID: 9134874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG; Moyle GJ
    Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV therapy advances. Pediatric antiretroviral choices.
    Spector SA
    AIDS; 1994 Sep; 8 Suppl 3():S15-8. PubMed ID: 7840911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined antiretroviral therapy for prevention of vertical HIV-1 transmission].
    Casas E; Gómez-Cano M; Adrados M; García-Lerma G; Calvo F; Soriano V
    An Med Interna; 1998 Mar; 15(3):148-51. PubMed ID: 9567423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of zidovudine, didanosine, zalcitabine and no antiretroviral therapy in patients with advanced HIV disease.
    Torres RA; Barr MR; McIntyre KI; Thornton JR; Shay WM; Feldman RD; George NJ; Britton DJ
    Int J STD AIDS; 1995; 6(1):19-26. PubMed ID: 7727578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.
    Newell ML; Gibb DM
    Drug Saf; 1995 Apr; 12(4):274-82. PubMed ID: 7646826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
    Baldeweg T; Catalan J; Gazzard BG
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):34-41. PubMed ID: 9667558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in anti-retroviral therapy of adults.
    Khoo SH; Wilkins EG
    J Antimicrob Chemother; 1995 Feb; 35(2):245-62. PubMed ID: 7759389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.
    D'Aquila RT; Johnson VA; Welles SL; Japour AJ; Kuritzkes DR; DeGruttola V; Reichelderfer PS; Coombs RW; Crumpacker CS; Kahn JO; Richman DD
    Ann Intern Med; 1995 Mar; 122(6):401-8. PubMed ID: 7856987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.